Condition: Pelvic Organ Prolapse · Sponsor: Promedon
This prospective, multi center cohort trial aims to evaluate the efficacy and safety of hysteropexy using Splentis via the vaginal route in primary uterine prolapse
This description comes directly from the study's public registry record.
Philipp Schelhorn · 00498031900400 · trials.de@promedon.com
Lorena López, Ph.D, Bioeng · 005493514596072 · lorena.lopez@promedon.com
Always discuss trial participation with your own doctor first.
| DRK Hospital Chemnitz-Rabenstein | Chemnitz, Germany | Recruiting |
| Helios Hospital Erfurt, Department of gynaecology | Erfurt, Germany | Recruiting |
| University Hospital Freiburg | Freiburg im Breisgau, Germany | Recruiting |
| Clinic Kassel | Kassel, Germany | Recruiting |
| St. Elisabeth Hospital | Leipzig, Germany | Recruiting |
| University Hospital | Mannheim, Germany | Not Yet Recruiting |
| Hospital Tettnang | Tettnang, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05042453